Home > News > Nucryst Looks to Zap Zits
March 10th, 2006
Nucryst Looks to Zap Zits
Jack Uldrich: Yesterday, Nucryst announced that it had been granted a new patent that covers the company’s poprietary nanocrystalline silver for treating acne.
Given the number of teenagers that still suffer from this vexing condition, the patent could prove to be very profitable for the company. In my estimation, however, this news alone is not enough to change my bearish opinion of Nucryst.
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013